SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-17-010748
Filing Date
2017-10-19
Accepted
2017-10-19 18:53:04
Documents
1
Period of Report
2017-10-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f3100917sorensen_dandritbio.html 3  
1 OWNERSHIP DOCUMENT f3100917sorensen_dandritbio.xml 3 3103
  Complete submission text file 0001213900-17-010748.txt   4531
Mailing Address STUMPEDYSSEVEJ 17, 2970 H?RSHOLM G7
Business Address STUMPEDYSSEVEJ 17, 2970 H?RSHOLM G7 45 39179840
DanDrit Biotech USA, Inc. (Issuer) CIK: 0001527728 (see all company filings)

IRS No.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address STUMPEDYSSEVEJ 17 HORSHOLM G7 2970
Business Address
Gronfeldt-Sorensen Henrik (Reporting) CIK: 0001720024 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-54478 | Film No.: 171145594